[1][2] DRAP is committed to ensuring that all drugs, medical devices,[3] cosmetics, alternative medicines, and health products meet a certain standard of quality and are safe and effective for use.
[4] It is responsible for making sure that therapeutic goods, which are approved and available in the market, comply with the prescribed standards of quality, safety, and efficacy.
[6][7] A committee was formed to propose strategies to alleviate the scarcity of life-saving medicines and liaise with pharmaceutical manufacturers and importers.
[8] In an effort to eradicate black market practices and put an end to hoarding, DRAP introduced a mobile application.
[9] Allegations have been made against Asim Rauf the CEO of DRAP for operating a Benami pharmaceutical company, which is perceived as a clear instance of conflict of interest.